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ABSTRACT
Objectives: To evaluate the validity of the American Diabetes Association (ADA Test) risk test as a
screening for prediabetes in a sample of Peruvian workers. Methods: Cross-sectional study of diagnostic
tests. Secondary analysis of the data generated by the electronic health record of an occupational
polyclinic, carried out in January and February 2020. The sample was made up of workers from different
areas who attended for their occupational medical evaluation. Prediabetes was considered with a fasting
glucose ≥ 100 mg / dl but less than 126 mg / dl. Results: 397 subjects were evaluated. The prevalence
of hyperglycemia was 29% (115/397). With a cutoff ≥ 3 points, the ADA Test presented an area under
the curve of 0.868, a sensitivity of 94.8%, and a specificity of 51.8%. The positive predictive value (PPV)
was 44.5% and the negative predictive value (NPV) was 96.1%. Finally, the positive likelihood coefficient
calculated was 1.96, and the negative was 0.101. Conclusions: The ADA test, with a 3-point cutoff, proves
to be a simple pragmatic screening tool for undiagnosed cases of prediabetes. Suppose current results are
confirmed in future research, due to their simplicity. In the case, it can facilitate various initiatives aimed at
introducing and expanding early prevention and management strategies based on this trial.
Key words: Prediabetic state; Diabetes mellitus; Screening; Primary prevention; Perú (source: MeSH NLM).

RESUMEN
Ojetivos: Evaluar la validez de la prueba de riesgo de la Asociación Americana de Diabetes (Prueba ADA)
como cribado para prediabetes en una muestra de trabajadores peruanos. Métodos: Estudio transversal
de pruebas diagnósticas. Análisis secundario de los datos generados por el registro electrónico en salud
de un policlínico ocupacional, realizado en los meses enero y febrero del año 2020. La muestra estuvo
conformada por trabajadores de diferentes áreas que asistieron para su evaluación médica ocupacional.
Se consideró prediabetes con una glucosa en ayunas ≥ 100 mg/dl pero menor a 126 mg/dl. Resultados:
Se evaluaron 397 sujetos. La prevalencia de prediabetes fue 29% (115/397). Con un corte ≥ 3 puntos, la
Prueba ADA presentó un área bajo la curva de 0.868, una sensibilidad del 94,8% y una especificidad
del 51,8%. El valor predictivo positio fue de 44,5% y negativo fue de 96,1%. Por último, el coeficiente
de verosimilitud positivo calculado fue de 1,96, y el negativo fue de 0,101. Conclusión: La prueba ADA,
con un corte de 3 puntos, demuestra ser una herramienta de detección pragmática simple para casos
no diagnosticados de prediabetes. Si los resultados actuales se confirman en investigaciones futuras,
debido a su simplicidad, puede facilitar diversas iniciativas orientadas a introducir y ampliar estrategias
de gestión y prevención temprana a partir de esta prueba.
Palabras clave: Estado prediabetes; Diabetes mellitus; Cribado; Prevención primaria; Perú (fuente: DeCS
BIREME).
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INTRODUCTION
Type 2 diabetes mellitus (DM2) is a progressive
disease that causes multiple complications over
time, both micro and macrovascular, increasing
cardiovascular mortality(1,2). Thus, DM2 is a serious
public health problem worldwide(3,4). For example,
in the United States (USA) and China, the prevalence
of DM2 is around 11.6%(5,6). While, in Peru, the
prevalence of DM2 is 7%, and the incidence is 19
cases per 1000 inhabitants(7,8).

The ADA test consists of 7 questions, with a score of
0-11 points. Initially, it has been used to detect a high
risk of DM2. If the score was greater than or equal
to 5 points, the patient has indicated a discarded
test for DM2(14). However, this test has shown good
screening values for prediabetes in other studies,
although these present different cut-off points,
depending on where the study was carried out(15–19).
Extrapolating these results to the Latino population,
particularly the Peruvian, is not recommended for
optimal clinical decision-making(20,21). Therefore,
starting from a workgroup, which is progressively
exposed to risk factors, such as age, stress, incorrect
eating behavior, among others(22–24), this research
proposes to estimate the diagnostic validity of the
ADA test as a screening for prediabetes in a sample
of Peruvian workers.

METHODS
Design
A cross-sectional study of diagnostic tests. Secondary
analysis of the data generated by the electronic
health record of an occupational polyclinic located
in Lima, Peru. This registry was carried out in January
and February of the year 2020.

Population and sample
The database included information on the results
of the occupational examinations carried out on

https://inicib.urp.edu.pe/rfmh/vol21/iss3/14
DOI: https://doi.org/10.25176/RFMH.v21i3.3614

In this studio, Workers who do not have fasting
glucose, with fasting glucose ≥ 126 mg/dl, pregnant
women were excluded, with a history of diabetes
or prediabetes, and took medications that modify
glucose levels. In that way, we worked with all the
evaluated individuals in the study period and fulfilled
the selection criteria. Consecutive non-probability
sampling was carried out.
The database included 417 workers. Once the
inclusion and exclusion criteria were applied, we
worked with 397 subjects.

Procedures
The flow chart of care in the medical center is detailed
below. When the worker arrived at the polyclinic,
he signed a letter of commitment at the reception,
declaring that all the information provided is
accurate. You were given a file with the medical
history to fill in your data. After that, the nursing team
measured the total height with a stadiometer, while
the weight was measured with an electronic scale,
but before the subject was instructed to wear light
clothing. All data were noted in the medical record.

ORIGINAL PAPER

Therefore, public health policies must focus on
detecting subjects in previous states, such as
prediabetes, which is a state that can be reversed
and thus prevent progression to DM2(9-11). However,
laboratory tests are not always available in primary
care settings(12). For this reason, the need to
implement a simple, rapid, and laboratory-free
detection method is impetuous(13). One of these tools
is the American Diabetes Association (Risk TestADA
TestADA Test Risk Score)(14).

workers who attended the Polyclinic. The workers
belong to the ages between 18 to 65 years, who
belonged to different employers in the City of Lima
- Peru, whose main work areas are administrative,
management, accountant, assistant, supervisor,
bricklayer, operator, driver, and analyst.

Subsequently, it is passed to the laboratory, where
the staff first verified that the worker had performed
at least 8 hours of fasting. Then, a 5 ml blood
sample was taken by venipuncture. The sample was
centrifuged for 5 minutes to separate the serum to be
processed in a Chemray 240 automatic equipment.
The workers who did not comply with the requested
fasting time did not take the laboratory test.
Finally, the worker went to the medical office of the
polyclinic, where the medical evaluation was carried
out. First, the occupational evaluating physician asked
her questions about her biological, pathological, and
family history. Then a physical exam was performed.
Subsequently, a musculoskeletal examination was
performed, where he was also asked about physical
activity. Finally, depending on the type of work, other
exams were indicated. All the data collected by the
occupational physician were noted in the medical
history.
An administrative staff registers all the information
in the clinical history in the polyclinic's database.
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Variables and instruments
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The ADA test is a questionnaire that consists of
7 variables, with a score of 0 to 11 points. These
variables are age: categorized as <40 years (0 points),
40-49 years (1 point), 50-59 years (2 points), 60 years
and over (3 points); sex: male (1 point) and female (0
points); history of gestational diabetes: yes (1 point)
and no (0 points); family history of diabetes: yes (1
point) and no (0 points); history of hypertension:
yes (1 point) and no (0 points); performance or not
of physical activity: yes (1 point) and no (0 points);
and weight: normal weight (0 points), overweight
(1 point), obesity (2 points) and morbid obesity (3
points)(25).
For the diagnosis of prediabetes, fasting glucose
was used. It was worked as a categorical variable. A
value <100 mg / dl was considered "normal", while
values between ≥ 100 mg / dl and <126 mg / dl were
classified as "prediabetes"(14).

Statistical analysis
The analysis was performed using Stata Software
version 15.0 (Stata Corp. College Station, TX, USA).
For descriptive analysis, qualitative variables were
summarized in proportions, while the quantitative
variables were presented as the mean and the
standard deviation by the normality distribution of
the age variable, which was evaluated through bias,
kurtosis, and histogram. According to the group of
the presence or not of prediabetes, the Fisher's exact
test or the Student's T-test was performed for the
bivariate analysis, depending on the nature of the
variable.
The analysis of ROC curves (an acronym for Receiver
Operating Characteristic, and their respective area
under the curve (AUC) were used as a statistical and
graphical method to evaluate the discriminative
diagnostic performance both for the test score. ADA
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and fasting glucose levels. Sensitivity, specificity,
positive (PPV) and negative predictive value (NPV),
and positive and negative likelihood ratio were
calculated with different cut-off points of the ADA
test. The Youden index and sensitivity values were
used to calculate the optimal cut-off point.

Ethical aspects
Only the variables of interest for the study were
requested from the polyclinic. The data provided
by the institution were anonymous, and access
to the study material was limited to the principal
investigator. For this reason, there was no contact
with human beings; therefore, the risks for the
subjects of analysis were minimal.
In addition, it had the permission of the institution
(polyclinic), and the research project was submitted
for evaluation by the Ethics Committee of the
Southern Scientific University (CIEI-Científica).

RESULTS
A total of 397 subjects were included. The
prevalence of prediabetes was 29%. The most
common characteristics observed were being male
(74.6%), being under 40 years of age (69%), and
the proportion of subjects who performed physical
activity (50.6%). The rest of the characteristics of the
participants can be observed in detail in Table 1. In
the bivariate analysis, all the variables associated
with the ADA Test were shown to be significantly
associated with respect to prediabetes.
Table 2 shows us that the ADA Test presented an
AUC of 0.87. In addition, with a cutoff ≥ 3 points, a
sensitivity of 94.8% and a specificity of 51.8% were
obtained; a PPV of 44.5% and an NPV of 96.1%;
finally, the positive likelihood coefficient calculated
was 1.96, and the negative was 0.101. In figure 2, you
can see the ROC curve according to the total.
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Table 1. Descriptive characteristics of the ADA Test in the study population and bivariate analysis regarding
the presence of prediabetes.
Prediabetes
Characteristics

Total (n=397)

no (n=282)

si (n=115)

n (%)

n (%)

n (%)

Gender

p*
0.036

Female

101 (25.4)

80 (79.2)

21 (20.8)

Male

296 (74.6)

202 (68.2)

94 (31.8)

35,35 (± 10,54)

32,66 (± 9,07)

41,95 (± 11)

Age (years)¶
Age (categorized)

<0.001
<0.001

274 (69)

225 (82.1)

49 (17.9)

40 - 49 years

79 (19.9)

45 (57.0)

34 (43)

50 - 59 years

35 (8.8)

10 (28.6)

25 (71.4)

≥ 60 years

9 (2.3)

2 (22.2)

7 (77.8)

Nutritional Status

<0.001
Normal weight

133 (33.5)

116 (87.2)

17 (12.8)

Overweight

180 (45.3)

123 (68.3)

57 (31.7)

Obesity I

69 (17.4)

41 (59.4)

28 (40.6)

Obesity II

15 (3.8)

2 (13.3)

13 (86.7)

Physical activity

ORIGINAL PAPER

< 40 years

<0.001
No

196 (49.4)

113 (57.7)

83 (42.4)

Yes

201 (50.6)

169 (84.1)

32 (15.9)

Family history of Diabetes Mellitus 2

0.012

No

266 (67)

202 (75.9)

64 (24.1)

Yes

131 (33)

80 (61.1)

51 (38.9)

Family history of Gestational Diabetes **

0.018

No

92 (91.1)

76 (82.6)

16 (17.4)

Yes

9 (8.9)

4 (40)

5 (55.6)

History of hypertension

0.012
No

388 (97.7)

279 (71.9)

109 (28.1)

Yes

9 (2.3)

3 (33.3)

6 (66.7)

ADA test

<0.001
< 3 points

254 (64)

235 (92.5)

19 (7.5)

≥ 3 puntos

143 (36)

47 (32.9)

96 (67.1)

* P-value calculated with the Chi-square test, except for the age variable (in years) that Student's t-test was used and for the antecedent
variable of gestational diabetes, that the Fisher's exact test was used
** It has only been taken take into account the female population.
¶
Mean plus standard deviation.
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Table 2. Diagnostic values according to the cut-off point of the ADA test for prediabetes.
Cut-off
point

Sens (%)

Esp (%)

VPP

VPN

Youden's
index

CV+

CV-

0

100

0

28.96

-

0

1

-

1

100

5.3

33.62

100

0.532

1.05

0

2

99.1

20.2

30.15

98.3

0.194

1.24

0.043

3

94.8

51.8

44.48

96.1

0.466

1.96

0.101

4

83.5

53.3

67.13

92.5

0.668

5

0.198

5

29.6

96.8

79.06

77.2

0.264

9.26

0.727

6

10.4

98.2

70.54

72.9

0.087

5.88

0.912

7

2.6

100

100

71.6

0.026

-

0.973

8

0.9

100

100

71.2

0.009

-

0.991

>8

0

100

-

-

-

-

1

Sens: sensitivity, Esp: specificity, PPV: positive predictive value, NPV : negative predictive value, CV +: positive likelihood coefficient, CV-:
negative likelihood coefficient.

1.00

0.75

0.50

0.25

0.00
0.00

0.25

Area under ROC curve = 0.8689

0.50

1-Specificity

0.75

1.00

Figure 1. ROC curve of the ADA Test with respect to the diagnosis of prediabetes.
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DISCUSSION
Due to the increase in the frequency of DM2 cases in
Peru, the prevention of this disease has become an
important priority in public health. It is important to
have a simple, rapid, and laboratory-free screening
tool(13) to detect elevated glucose levels prior to the
state of DM2, even in the absence of biochemical
analysis. To our knowledge, this is the first study to
examine this test in the Peruvian population.

This cut-off point differs from that found in other
studies. In the US and China, the ADA test was used
to detect diabetes, with a cut-off point of 3 and 5
points, respectively. In the Philippines, the cut-off
point established for prediabetes and diabetes was
4 points(15,17,19). The study carried out in South India
used the ADA test, but without comparison with any
other diagnostic test, and only compared the cut-off
point of 5 points for prediabetes, using glycosylated
hemoglobin(16).
Its use in the Latino population so far has only
been evaluated in Latinos residing in the United
States, considering glycosylated hemoglobin as GS,
to detect prediabetes, using a cut-off point of 4.
However, all the population studied were women(18 ).
Although the main explanation for these differences
found with other studies was that the methodology
was not the most suitable, we must also consider the

https://inicib.urp.edu.pe/rfmh/vol21/iss3/14
DOI: https://doi.org/10.25176/RFMH.v21i3.3614

The limitations of this study should be considered.
First, the subjects belong to the labor group.
Therefore, the results of the ADA test may not be
totally representative of the working population
nor of the Peruvian population; however, it is
possible that they have similar conditions, and some
inference can be made. Second, while there are two
more methods to diagnose this disease, which are
glycosylated hemoglobin and glucose tolerance
test, the results obtained by fasting glucose will give
us a reliable result, so the final results will not be far
from the actual value of the test.
Due to the importance of detecting prediabetes
in areas where there is no access to conventional
laboratory tests, it is recommended to continue
carrying out studies with respect to the ADA Test
in other Peruvian populations. In this way, it would
work with a more representative sample. It will be
possible to corroborate whether the behavior of
said test as a screening method for prediabetes is
maintained.

ORIGINAL PAPER

The AUC of the ADA Test was high (0.87),
demonstrating the ability of this test to approach the
BG. The cut-off point for detecting prediabetes in the
present study was 3. In this way, we can use it as a
screening method due to its high sensitivity, where,
out of every 100 people who undergo this test, 95
subjects with prediabetes would be detected.

differences between the population characteristics
between these countries. This shows that the
same cut should not always be used for a certain
pathology(20).

CONCLUSION
With a 3-point cutoff, the ADA test proves to be a
pragmatic and straightforward screening tool for
undiagnosed cases of prediabetes. Suppose current
results are confirmed in future research due to
their simplicity. In that case, it can facilitate various
initiatives aimed at introducing and expanding early
prevention and management strategies based on
this trial.
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